Cancer

In this video Sandeep Gurram, MD, a urologic oncologist at the National Cancer Institute in Bethesda, Maryland, discusses a study on the novel diagnostic tool, the miR Sentinel PCC4 Test, presented at the American Urological Association's annual meeting.

In this video, Stacy Loeb, MD, professor in the department of urology at NYU Grossman School of Medicine, discusses studies looking at genetic counseling and its effect on the management of advanced prostate cancer.

Surveillance of patients carrying the CDKN2A gene mutation led to earlier detection of pancreatic ductal adenocarcinoma which improved disease prognosis, according to a presenter at UEG Week.

Systemic lupus erythematosus is a risk factor for increased mortality in elderly patients with early breast cancer, according to data published in Arthritis Care & Research.

In this video, Eugene Shenderov, MD, PhD, assistant professor of oncology at Johns Hopkins Sidney Kimmel Comprehensive Cancer Center in Baltimore, MD, discusses two posters on prostate cancer therapies presented at the ESMO Congress 2021.

In this video, Eugene Shenderov, MD, PhD, assistant professor of oncology at Johns Hopkins Sidney Kimmel Comprehensive Cancer Center in Baltimore, MD, discusses a phase I/II multicenter first-in-human trial of DS-7300, an anti-B7-H3, which was studied in patients with advanced solid tumors.

Following cancer diagnosis, there was a higher incidence of nonfatal self-injury than suicide, according to a population-based, retrospective cohort study in JAMA Network Open.

In this video Andres Correa, MD, discusses the MiR Sentinel PCC4 test, which has been shown to offer a high predictive value when testing for prostate cancer.

In this video Andres Correa, MD, discusses several abstracts looking at focal therapy for prostate cancer presented at the American Urological Association's annual meeting.

In this video Andres Correa, MD, discusses abstracts presented at the American Urological Association's annual meeting that investigated the impact of COVID 19 on different subpopulations of prostate cancer.